Navigation Links
NuVasive to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference
Date:7/29/2009

SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Patrick Williams, Vice President of Finance and Investor Relations, is scheduled to present at the BMO Capital Markets Focus on Healthcare Conference at The Millennium Broadway Hotel in New York, New York, on Wednesday, August 5, 2009, at 11:15 a.m. ET.

A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.nuvasive.com. After the live webcast, the presentation will remain available on the website for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused primarily on the $4.6 billion U.S. spine implant market. Additionally, the Company has expanded into the $1.5 billion global biologics market, the $1.5 billion international market, and is developing products for the emerging motion preservation market.

NuVasive's principal product offering is based on its Maximum Access Surgery, or MAS(R) platform. The MAS platform combines four categories of products that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: NeuroVision(R), a proprietary software-driven nerve avoidance system; MaXcess(R), a unique split-blade retractor system; a wide variety of specialized implants; and several biologic fusion enhancers. MAS significantly reduces surgery time and returns patients to activities of
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference
2. NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results
3. NuVasive Licenses Its Insert and Rotate Technology
4. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
5. NuVasive to Present at BIOCOM Investor Conference 2007
6. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
7. NuVasive to Offer $200 Million Convertible Senior Notes Due 2013
8. NuVasive Prices $200 Million Convertible Senior Notes Due 2013
9. NuVasive Reports First Quarter 2008 Financial Results
10. NuVasive Acquires First Stem Cell Bone Graft Substitute
11. NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... that as many as 10 million older Americans suffer ... and isolation. , However, new research a project ... Americans for six years found that Internet use ... by more than 30 percent. , "That,s a very ... professor of telecommunication, information studies and media who led ...
(Date:4/17/2014)... 17, 2014 By discovering a new mechanism that ... stroke, researchers at UC Irvine and the Salk Institute ... limit or prevent stroke-induced brain damage. , A complex ... of death and primary reason for disability in the ... stroke and lets blood-borne material into the brain, causing ...
(Date:4/17/2014)... Calif.) An international team led by researchers at ... complex, which plays a key role in cell division, ... This is the first time the complex has been ... make cyclin B1/Cdk1 an excellent target to control cellular ... The research was published online today in the journal ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
Breaking Medicine News(10 mins):Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... FamilyLife, the global, non-profit leader,in marriage conferences, ... Feb.,13 - 15. The Weekend to Remember ... troubled ones in an engaging, supportive and,non-threatening environment. ... Dennis Rainey, president, CEO and co-founder of FamilyLife. ...
... particle syringe composed of polymer layers and nanoparticles may ... the rest of the body, according to a team ... and flexible enough to deliver a variety of substances., ... than they fear the disease they treat," says Huda ...
... Jan. 12 Advanced Sterilization Products (ASP) is ... Indicator readout time has significantly improved from a ... Now, STERRAD(R) System customers can safely record biological ... instrument throughput in the sterilization department. The product ...
... worthy cause at Access Hollywood,s 3rd Annual "Stuff ... Theater Network.LOS ANGELES, Jan. 12 CVS/pharmacy, America,s ... two important charities on behalf of celebrities attending ... The donations are a part of CVS/pharmacy,s ...
... 12 Sam,s Club is hosting a,Pharmacy Challenge and ... where consumers can check prices on their prescriptions and,over-the-counter ... any competitor price on branded prescriptions. Membership is ... "Your Healthy Year" promotes a variety ...
... Industry Veteran Steve Shulman to BoardHOUSTON, Jan. 12 ... largest provider of outsourced medical implantable device management ... that its board of directors has appointed board ... announced the appointment following its second consecutive year ...
Cached Medicine News:Health News:FamilyLife Co-Founder and Author Dr. Dennis Rainey Challenges Metroplex Couples to Celebrate Healthy Marriages this Valentine's Day 2Health News:FamilyLife Co-Founder and Author Dr. Dennis Rainey Challenges Metroplex Couples to Celebrate Healthy Marriages this Valentine's Day 3Health News:Tiny capsules deliver 2Health News:STERRAD(R) CYCLESURE(R) Biological Indicator is now 24 Hours, Accelerating Instrument Throughput 2Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 2Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 3Health News:Sam's Club(R) Hosts Pharmacy Challenge 2Health News:Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board 2Health News:Access MediQuip Appoints Former Priority Healthcare CEO to Chairman of the Board 3
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
(Date:1/15/2014)... Medical is very pleased to announce the appointment of Mr. ... Officer.  Mark was promoted from his current role of Chief ... facilities in Massachusetts , Mississippi ... in 2012 with 20+ years of broad-based operations, sales, engineering ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Mich. , May 19 Stryker Corporation (NYSE: ... has informed the Company that the actions undertaken to address issues raised ... , , , ... Warning Letter from FDA regarding compliance with certain quality system requirements at ...
... SAN FRANCISCO, Calif. , May 19 ... studies was published in The Lancet on ... elevated levels of lipoprotein-associated phospholipase A2 (Lp-PLA2), a vascular-specific ... coronary heart disease similar in magnitude to that with ...
Cached Medicine Technology:Stryker Announces Resolution of Two FDA Warning Letters 2Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 2Large Meta-Analysis Further Validates Benefit of Measuring Lp-PLA2 for Coronary Heart Disease and Ischemic Stroke Risk Assessment 3
... highly effective immobilization of the cervical and ... comfort that makes it well tolerated by ... in going from a stand-alone cervical collar, ... to a four-post orthosis. For these reasons, ...
... Until now, laborious custom fabrication was required ... was limited and modifications in response to ... cumbersome.,The GunSlinger evolved from two years of ... teaching hospital. This orthosis can be quickly ...
... is designed for the management of ... fractures. The lightweight anatomical design achieves ... for optimal control of humeral segments ... shoulder and elbow joints. In addition ...
... therapeutic benefits of controlled compression and cold, ... pain. The anatomically designed cuff provides complete ... can be ordered with an extra long ... circumferences.,All Cryo/Cuffs can be ordered as a ...
Medicine Products: